nmdae
Showing 1 - 6 of 6
Bipolar I Disorder Trial (NMDAE, Placebo Cap)
Not yet recruiting
- Bipolar I Disorder
- NMDAE
- Placebo Cap
- (no location specified)
Aug 3, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Mar 9, 2022
MDD Trial in Taichung (NMDAE, Placebo Cap)
Recruiting
- Major Depressive Disorder
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Jan 25, 2022
MDD Trial in Taichung (NMDAE, Sertraline, Placebo Cap)
Recruiting
- Major Depressive Disorder
- NMDAE
- +2 more
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Nov 16, 2021
Prodromal Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Recruiting
- Prodromal Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Nov 2, 2021